Transcatheter Aortic Valve Replacement (TAVR)
What is Transcatheter Aortic Valve Replacement (TAVR)?
This revolutionary treatment option provides an important therapy for patients with aortic valve stenosis who are at high risk for conventional open valve surgery.
During the TAVR procedure, Hoag’s experienced multidisciplinary team delivers a collapsible artificial valve into the heart through a catheter. Utilizing advanced imaging technology, this thin-flexible tube is inserted into the body through the groin, or a small incision between the ribs. The artificial heart valve is then inserted across the patient’s own aortic valve where it almost immediately goes to work.
Who is a Candidate for TAVR?
Not all patients are a candidate for transcatheter aortic valve replacement. In most cases, TAVR is used for patients who are considered at high surgical risk or inoperable. At Hoag, this procedure is also available for intermediate-risk patients. We have also been selected to offer a clinical trial for low-risk patients—please speak with your Hoag Cardiologist to determine which treatment approach is right for you.
Why Choose Hoag for Valve Replacement Surgery?
By combining first-rate imaging capabilities within an advanced operating suite, Hoag’s world-renowned cardiac surgeons and cardiologists now have unprecedented flexibility in real time to do what’s best for the patient. This results in safer treatment, shorter hospital stays, faster recoveries and improved outcomes.
Hoag’s highly skilled surgical team has access to the Bob & Marjie Bennett Advanced Cardiovascular Surgery Suite (Hybrid CVOR). The first operating room of its kind in Orange County, Hoag’s Hybrid CVOR enables advanced diagnostic imaging and surgical procedures to be performed simultaneously in the same room.
TAVR Clinical Trials
Our expert cardiac team is well-versed in the full array of heart valve surgical options, and can offer the best option for each patient. Hoag is one of a select few centers in the nation to offer clinical trials evaluating TAVR.
Recognized when it matters
Hoag has been recognized by U.S. News & World Report as a high-performing hospital in 2023-2024 and ranked in the top 10% in the nation for five cardiac specialties. As the first hospital in Orange County to offer TAVR, Hoag was also the first to achieve 500 TAVR procedures. Thanks to philanthropy, Hoag is the first center in Orange County to offer TAVR as an option for patients who otherwise would’ve been denied treatment.
Meet the Team
The Jeffrey M. Carlton Heart & Vascular Institute has an experienced and extensively trained multidisciplinary team that performs each Transcatheter Aortic Valve Replacement (TAVR). This team consists of cardiologists, interventionalists, cardiac anesthesiologists, cardiac surgeons, and a nurse coordinator.
-
Anthony D. Caffarelli, MD Physician Leader, Newkirk Family Endowed Chair in Aortic Care, Director, Elaine & Robert Matranga Aortic Center, Director, Hoag Cardiac Surgery
-
Asad A. Shah, MD Physician Leader, Co-Director, Hoag Cardiovascular Surgery, Cardiothoracic Surgeon
-
Mahmoud R. Eslami-Farsani, MD Physician Leader, Medical Director, Cardiology, Cardiac Cath Lab, Cardiologist, Interventional Cardiology
-
Subbarao V. Mylavarapu, MD Physician Leader, Dr. Joel H. Manchester Endowed Chair in Interventional Cardiology, Medical Director, Cardiac Cath Labs, Program Director, Cardiac Catheterization Laboratories
-
Jorge M. Castellanos, MD TAVR Interventionalist, Cardiologist
-
Natesa G. Pandian, MD Physician Leader, Director, Nancy & Bill Thompson Heart Valve Center, Director, Noninvasive Cardiac Imaging
-
Cheng-Han Chen, MD TAVR Interventionalist
We are here for you
The Jeffrey M. Carlton Heart & Vascular Institute is one of the preeminent cardiovascular centers on the West Coast, and is well respected for delivering quality care and exceptional patient outcomes in the areas of valve disease, vascular disease and cardiac arrhythmia.